The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Repeated opening of the blood-brain barrier with the skull-implantable SonoCloud-9 (SC9) device: Phase 1 trial of nab-paclitaxel and SC9 in recurrent glioblastoma.
 
Adam M. Sonabend
Honoraria - Teladoc
Research Funding - Agenus
Patents, Royalties, Other Intellectual Property - I am a co-author on patents filed by Northwestern University related to novel treatments for brain tumors. No licensing or financial benefit so far. (Inst)
Other Relationship - Carthera (Inst); Celgene/Bristol-Myers Squibb (Inst)
 
Andrew Gould
No Relationships to Disclose
 
Yu Luan
No Relationships to Disclose
 
Ye Hou
No Relationships to Disclose
 
Li Chen
No Relationships to Disclose
 
Mikoto A. Kobayashi
No Relationships to Disclose
 
Brandyn A. Castro
No Relationships to Disclose
 
Daniel Y. Zhang
No Relationships to Disclose
 
Farida V. Korobova
No Relationships to Disclose
 
Christina Amidei
No Relationships to Disclose
 
John F. Bebawy
No Relationships to Disclose
 
Benjamin P Liu
Research Funding - Bayer; Guerbet
 
Craig M. Horbinski
No Relationships to Disclose
 
Carole Desseaux
Employment - Carthera
Stock and Other Ownership Interests - CarThera
 
Irene B. Helenowski
No Relationships to Disclose
 
Hui Zhang
No Relationships to Disclose
 
Miguel M Muzzio
No Relationships to Disclose
 
Feng Yue
No Relationships to Disclose
 
Michael Canney
Employment - CarThera
Leadership - CarThera
Stock and Other Ownership Interests - CarThera
Patents, Royalties, Other Intellectual Property - CarThera
 
Roger Stupp
Stock and Other Ownership Interests - Alpheus Medical
Consulting or Advisory Role - AstraZeneca; Boston Biomedical; Boston Scientific; Carthera; Celgene; Celularity; CranioVation; GT Medical Technologies; Hemispherian; InSightec; Northwest Biotherapeutics; Novocure; The Lockwood Group; Triact Therapeutics; Zai Lab
Research Funding - Bristol-Myers Squibb/Celgene (Inst); CarThera
Patents, Royalties, Other Intellectual Property - METHODS OF DETERMINING RESPONSIVENESS TO CHEMOTHERAPEUTIC COMPOUNDS FOR CANCER THERAPY Type: Provisional Serial No. 63/202,761 Filed: 6/23/2021 (Inst)